ACA Compliance Bulletin: Upcoming ACA Reporting Deadlines
Upcoming ACA Reporting Deadlines
Upcoming ACA Reporting Deadlines
Here is the September 2024 issue of our Penniall & Associates, Inc., Benefits Buzz Newsletter.This month’s Benefits Buzz newsletter discusses the DOL’s updated model employer CHIP notice and the upcoming deadline for issuing MLR rebates…
The September 2023 issue of our Penniall & Associates, Inc., Benefits Buzz Newsletter. This month’s Benefits Buzz newsletter discusses the affordability percentage for 2024 under the ACA’s pay or play rules and the upcoming deadline…
This month’s Benefits Buzz Newsletter discusses the current status of the ACA’s preventive care mandate and reminds employers with self-funded health plans about the upcoming PCORI fee deadline. In addition, we’re attaching the July 2023…
The U.S. Department of Treasury and the U.S. Small Business Administration (SBA) recently announced updates to eligibility for Payment Protection Program (PPP) loan applications, allowing borrowers to apply through larger lenders. To learn more, click…
Like many other people, you may be thinking about what you would like to accomplish in 2021 or what life changes you could make. Common New Year’s resolutions include losing weight, exercising, getting organized, learning…
On Dec. 11, 2020, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Pfizer Inc.’s COVID-19 vaccine. This EUA allowed distribution of the vaccine to begin immediately in the United States.…
On Dec. 12, 2020, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) recommended use of Pfizer Inc.’s COVID-19 vaccine for individuals 16 years of age and older.…
The IRS has added or updated more than 80 answers to questions in its series of FAQs on “COVID-19-Related Tax Credits for Required Paid Leave Provided by Small and Midsize Businesses.” The changes affect questions…
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for drugmaker Pfizer Inc.’s COVID-19 vaccine, developed in partnership with German drugmaker BioNTech. This EUA allows distribution of the vaccine to…